Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
The study was conducted between 29 June 2017 and 05 October 2017.
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
yes
Remarks:
The deviation was considered to have not affected the integrity or validity of the study.
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
bis(cyclohexylmethyl) ether
Cas Number:
14315-63-0
Molecular formula:
C14H26O
IUPAC Name:
bis(cyclohexylmethyl) ether
Test material form:
liquid
Remarks:
Clear, colorless
Specific details on test material used for the study:
Identification: FRET 13-0460
Physical state/appearance: clear colorless liquid
Storage Conditions: approximately 4 °C in the dark

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
Animal Information
Male and female RccHan™ : WIST strain rats were supplied by Envigo RMS (UK) Limited, Oxon, UK. On receipt the animals were randomly allocated to cages. After an acclimatization period of at least 5 days the animals were given a number unique within the study by ear punching and a number written on a color coded cage card. At the start of the study the animals were approximately 8 to 12 weeks old and within the weight range of 200 g to 350 g. The females were nulliparous and non pregnant.

Animal Care and Husbandry
The animals were housed in groups of up to five by sex in solid floor polypropylene cages with stainless steel lids, furnished with softwood flakes. With the exception of the exposure period, free access to mains drinking water and food (2014C Teklad Global Rodent diet supplied by Envigo RMS (UK) Limited, Oxon, UK) was allowed throughout the study. The diet, drinking water and bedding were routinely analyzed and were considered not to contain any contaminants that would reasonably be expected to affect the purpose or integrity of the study.
The temperature and relative humidity were set to achieve limits of 19 to 25 °C and 30 to 70% respectively. The rate of air exchange was at least fifteen changes per hour and the lighting was controlled by a time switch to give 12 hours continuous light and 12 hours darkness. The animals were retained in this accommodation at all times except during the exposure period.
The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose only
Vehicle:
air
Mass median aerodynamic diameter (MMAD):
2.65 µm
Geometric standard deviation (GSD):
2.28
Details on inhalation exposure:
Atmosphere Generation
The test item was aerosolized using a metal concentric jet nebulizer (Envigo CRS Limited, UK) located at the top of the exposure chamber. The nebulizer was connected to a glass syringe attached to an infusion pump, which provided a continuous supply of test item under pressure, and to a metered compressed air supply.
Compressed air was supplied by means of an oil free compressor and passed through a water trap and respiratory quality filters before it was introduced to the nebulizer.
The cylindrical exposure chamber had a volume of approximately 30 liters (dimensions: 28 cm diameter x 50 cm high). The concentration within the exposure chamber was controlled by adjusting the rate of the infusion pump. The extract from the exposure chamber passed through a ‘scrubber’ trap and was connected with a high efficiency filter to a metered exhaust system. The chamber was maintained under negative pressure.
Homogeneity of the test atmosphere within the chamber was not specifically determined during this study. Chambers of the same design (ADG Developments Ltd, Hitchin, Herts, UK) have been fully validated and shown to produce evenly distributed atmospheres in the animals’ breathing zone with a wide variety of test items (Green J D et al, 1984).
Prior to the start of the study, test item atmospheres were generated within the exposure chamber. During this characterization period test item input rates were varied to achieve the required atmospheric conditions.

Exposure Procedure
During the exposure period, each rat was individually held in a tapered, polycarbonate restraining tube fitted onto a single tier of the exposure chamber and sealed by means of a rubber ‘O’ ring. Only the nose of each animal was exposed to the test atmosphere.
Following an appropriate equilibration period a single group of ten rats (five males and five females), was subjected to a single exposure to the test item for a period of four hours. A target concentration of 5.0 mg/L was used for the exposure. As the mean achieved concentration was 102% of target and no deaths occurred, no further levels were required.

Exposure Chamber Temperature and Relative Humidity
The temperature and relative humidity inside the exposure chamber were measured by an electronic thermometer/humidity meter (Hanna Instruments Ltd, Beds., UK) located in a vacant port in the animals’ breathing zone of the chamber and recorded every 30 minutes throughout the 4 Hour exposure period.

Exposure Chamber Oxygen Concentration
Oxygen levels within the exposure chamber were measured by an electronic oxygen analyzer (Servomex (UK) Ltd, Crowborough, East Sussex) located in a port in the animals breathing zone during the 4 Hour exposure period. The test atmospheres were generated to contain at least 19% oxygen.

Exposure Chamber Atmosphere Concentration
Prior to the inhalation phase of the study, the non-volatile component of the test item was determined by adding a small, known amount of test item to glass fiber filters and recording their weights. The filters were then dried in a desiccator at room temperature for approximately 24 hours and then weighed again. The difference in the two weights was taken as the volatile content of the test item and the non-volatile component was calculated as a percentage. The mean non-volatile component of the batch used during the formal exposure was found to be 69.78 % (n=8). A significant difference between the expected and achieved concentrations was noted during generation trials therefore it was considered that gravimetric analysis would not be accurate and that chemical analysis would be required.
The test atmosphere was sampled nine times during the exposure period. A weighed glass fiber filter was placed in a filter holder and temporarily sealed in a vacant port of the exposure chamber in the animals’ breathing zone. A known quantity of the exposure chamber atmosphere was drawn through the filter using a vacuum pump. The samples were then submitted for chemical analysis.
The nominal chamber concentration was calculated by dividing the mass of test item disseminated into the chamber by the total volume of air that flowed through the chamber during the exposure.
The nominal concentration was 373% of the actual mean achieved atmosphere concentration and shows that keeping the aerosol airborne was relatively straightforward.

Particle Size Distribution
The particle size of the generated atmosphere inside the exposure chamber was determined three times during the exposure period using a Marple Personal Cascade Impactor (Westech IS Ltd, Beds., UK). This device consisted of six impactor stages (10.4, 7.7, 4.1, 1.3, 0.90 and 0.56 µm cut points) with stainless steel collection substrates and a backup glass fiber filter, housed in an aluminum sampler. The sampler was temporarily sealed in a sampling port in the animals’ breathing zone and a suitable, known volume of exposure chamber air was drawn through it using a vacuum pump.
The collection substrates and backup filter were weighed before and after sampling and the weight of test item, collected at each stage, calculated by difference.
The mean amount for each stage was used to determine the cumulative amount below each cut-off point size. In this way, the proportion (percentage) of aerosol less than 10.4, 7.7, 4.1, 1.3, 0.90 and 0.56 µm was calculated.
The resulting values were converted to probits and plotted against Log10 cut point size. From this plot, the Mass Median Aerodynamic Diameter (MMAD) was determined (as the 50% point) and the geometric standard deviation was calculated. In addition the proportion (percentage) of aerosol less than 4 µm (considered to be the inhalable fraction) was determined.
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
A target concentration of 5.0 mg/L was used for the exposure.
No. of animals per sex per dose:
5 males and 5 females
Control animals:
no
Details on study design:
Serial Observations
Clinical Signs
All animals were observed for clinical signs at hourly intervals during exposure, immediately on removal from the restraining tubes at the end of exposure, 1 hour after termination of exposure and subsequently once daily for 14 days. Any evidence of overt toxicity was recorded at each observation.

Body Weight
Individual body weights were recorded on arrival, prior to treatment on the day of exposure (Day 0) and on Days 1, 3, 7 and 14.

Terminal Investigations
Necropsy
All animals were subjected to a full external and internal examination and any macroscopic abnormalities were recorded. The respiratory tract was subjected to a detailed macroscopic examination for signs of irritancy or local toxicity.

Data Evaluation
Data evaluations included the relationship, if any, between the animals’ exposure to the test item and the incidence and severity of all abnormalities including behavioral and clinical observations, necropsy findings, body weight changes, mortality and any other toxicological effects.
Using the mortality data obtained, an estimate of the acute inhalation median lethal concentration (LC50) of the test item was made.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 5.11 mg/L air
Based on:
test mat.
Exp. duration:
4 h
Mortality:
No mortality was observed.
Clinical signs:
other: Signs of hunched posture and pilo-erection are commonly seen in animals for short periods on removal from the chamber following 4-hour inhalation studies. Wet fur is commonly recorded both during and for a short period after exposure. These observations
Body weight:
All animals exhibited body weight loss or no body weight gain on the first day post-exposure. With the exception of one female from Days 1 to 3 post-exposure and three females from Days 3 to 7 post-exposure which exhibited body weight loss, body weight gains were noted for all animals during the remainder of the recovery period.
Gross pathology:
No macroscopic abnormalities were detected amongst animals at necropsy.

Any other information on results incl. tables

 Exposure Chamber Concentration

The actual concentration of the test item was determined by gas chromatography (GC) using an external standard technique. The test atmosphere was sampled nine times and the actual concentration of the test item calculated. The mean values obtained were as follows:

Group Number

Atmosphere Concentration

Mean Achieved (mg/L)

Standard Deviation

Nominal (mg/L)

1

5.11

0.29

19.04

The chamber flow rate was maintained at 40 L/min providing 80 air changes per hour.

The theoretical chamber equilibration time (T99) was 4 minutes[1](Silver, 1946).

Particle Size Distribution

The particle size analysis of the atmosphere drawn from the animals’ breathing zone was as follows:

Group Number

Mean Achieved Atmosphere Concentration (mg/L)

Mean Mass Median Aerodynamic Diameter (µm)

Inhalable Fraction

(% <4 µm)

Geometric Standard Deviation

1

5.11

2.65

69.2

2.28

[1]= The test atmosphere was generated for a total of 11 minutes prior to animal insertion to ensure the target test item concentration was being achieved.

Temperature and Relative Humidity in Exposure Chamber

Time
(minutes)

Chamber Temperature (ºC)
During Exposure

Chamber Relative Humidity (%) During Exposure

0

21

41

30

21

40

60

21

43

90

21

41

120

21

41

150

21

44

180

21

44

210

21

42

240

21

42

Air Flow and Oxygen Concentration in Exposure Chamber

Time
(minutes)

Air Flow (L/minute)
During Exposure

Oxygen Concentration
During Exposure

-11*

40

-

0

40

20.9

30

40

-

60

40

-

90

40

-

120

40

20.9

150

40

-

180

40

-

210

40

-

240

40

20.9

*= Test atmospheres were generated for a total of 11 minutes prior to animal insertion to ensure the target test item concentration was being achieved.

-=    Not determined

Exposure Chamber Atmosphere Concentrations

Duration of Exposure (minutes)

Volume of Air Sampled (L)

Chamber Flow Rate (L/min)

Atmosphere Concentration (mg/L)

10

2

40

4.62

30

2

40

4.92

60

2

40

4.99

90

2

40

4.99

120

2

40

5.14

150

2

40

5.17

180

2

40

5.35

210

2

40

5.20

230

2

40

5.65

 

Mean achieved atmosphere concentration (mg/L)

 

=5.11

Standard deviation

=0.29

 

Nominal concentration:

 

Test item used (g)

191.2

Air flow (L/minute)

40

Total generation time (minutes)

251[1]

Nominal concentration (mg/L)

19.04

[1]= Test atmospheres were generated for a total of 11 minutes prior to animal insertion to ensure test item concentration was being achieved.

Particle Size Distribution

Cascade Impactor Data

Impactor Stage Number

Cut Point
(µm)

Amount Collected (mg) per Sample Number

Mean Amount Collected (mg)

1

2

3

3

10.4

0.05

0.12

0.09

0.09

4

7.7

0.13

0.18

0.15

0.15

5

4.1

0.35

0.43

0.35

0.38

6

1.3

0.49

0.60

0.55

0.55

7

0.90

0.49

0.54

0.41

0.48

8

0.56

0.18

0.16

0.10

0.15

Back-up Filter

<0.56

0.00

0.08

0.00

0.03

Total Mean Amount of Test Item Collected

1.83

Calculation

Cut Point

(µm)

Log10
Cut Point

Mean Cumulative Amount Less Than Cut Point

(mg)

(%)

Probit

10.4

1.017

1.74

95.1

6.65

7.7

0.887

1.59

86.9

6.12

4.1

0.613

1.21

66.1

5.42

1.3

0.114

0.66

36.1

4.64

0.90

-0.046

0.18

9.84

3.71

0.56

-0.252

0.03

1.64

2.87

 

Results

 

 

 

Mean Mass Median Aerodynamic Diameter

=2.65µm

Geometric Standard Deviation

=2.28

Predicted amount less than 4 µm

=69.2%

Mortality Data

Group Number

Mean Achieved Atmosphere Concentration (mg/L)

Sex

Deaths During Exposure

Deaths Post Exposure
(1 Hour)

Deaths During Day of Observation

Total Deaths

1

2

3

4

5

6

7

8-14

1

5.11

Male

0

0

0

0

0

0

0

0

0

0

0/10

Female

0

0

0

0

0

0

0

0

0

0

Individual Clinical Observations – (Day of Exposure)

Mean Achieved Atmosphere Concentration (mg/L)

Animal Number and Sex

Effects Noted During Exposure
(Hours)

Effects Noted on Removal from Chamber

Effects Noted 1 Hour Post Exposure

1

2

3

5.11

1 Male

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

2 Male

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

3 Male

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

4 Male

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

5 Male

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

6 Female

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

7 Female

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

8 Female

WfRd

WfRd

WfRd

WfHPRdRs

WfHPRd

9 Female

WfRd

WfRd

WfRd

WfHPRdRs

WfHPRd

10 Female

WfRd

WfRd

WfRd

WfHPRd

WfHPRd

Wf = Wet fur                        

Rd = Decreased respiratory rate                      

H=Hunched posture                          

P = Pilo-erection                                 

Rs = Sneezing

Individual Clinical Observations – Recovery Period

Mean Achieved Atmosphere Concentration (mg/L)

Animal Number and Sex

Effects Noted Post Exposure
(Days)

1

2

3

4

5

6

7

8-14

5.11

1 Male

HP

0

0

0

0

0

0

0

2 Male

HP

0

0

0

0

0

0

0

3 Male

HP

H

0

0

0

0

0

0

4 Male

HP

0

Rn

Rn

Rn

0

0

0

5 Male

HPRnRs

HRnRs

0

0

0

0

0

0

6 Female

HP

H

0

0

0

0

0

0

7 Female

HP

0

0

0

0

0

0

0

8 Female

HPRs

HRs

0

0

0

0

0

0

9 Female

HP

H

0

0

0

0

0

0

10 Female

HP

H

0

0

0

0

0

0

H=Hunched posture                          

P = Pilo-erection                                 

Rn = Noisy respiration                      

Rs = Sneezing                      

0 = No abnormalities detected

Individual Body Weights and Body Weight Changes

Mean Achieved Atmosphere Concentration (mg/L)

Animal Number and Sex

Body Weight (g) at Day

Body Weight Change (g) During Days

-8

0

1

3

7

14

-8 to 0

0 to 1

1 to 3

3 to 7

7 to 14

5.11

1 Male

202

248

234

245

259

291

46

-14

11

14

32

2 Male

204

247

239

253

271

304

43

-8

14

18

33

3 Male

206

250

237

245

263

303

44

-13

8

18

40

4 Male

198

231

220

225

235

260

33

-11

5

10

25

5 Male

202

245

237

241

264

295

43

-8

4

23

31

6 Female

196

215

208

215

220

224

19

-7

7

5

4

7 Female

204

210

207

213

211

219

6

-3

6

-2

8

8 Female

207

222

222

221

226

243

15

0

-1

5

17

9 Female

201

218

212

229

224

235

17

-6

17

-5

11

10 Female

192

200

200

204

203

209

8

0

4

-1

6

 

 Individual Necropsy Findings

Mean Achieved Atmosphere Concentration (mg/L)

Animal Number
and Sex

Time of Death

Macroscopic Observations

5.11

1 Male

Terminal Kill Day 14

No abnormalities detected

2 Male

Terminal Kill Day 14

No abnormalities detected

3 Male

Terminal Kill Day 14

No abnormalities detected

4 Male

Terminal Kill Day 14

No abnormalities detected

5 Male

Terminal Kill Day 14

No abnormalities detected

6 Female

Terminal Kill Day 14

No abnormalities detected

7 Female

Terminal Kill Day 14

No abnormalities detected

8 Female

Terminal Kill Day 14

No abnormalities detected

9 Female

Terminal Kill Day 14

No abnormalities detected

10 Female

Terminal Kill Day 14

No abnormalities detected

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Remarks:
4 hour LD50 is >5.11 mg/L
Conclusions:
The acute inhalation median lethal concentration (4 hour LC50) of FRET 13-0460 was greater than 5.11 mg/L.
Executive summary:

FRET 13-0460 was assessed for acute toxicity via inhalation using testing guideline OECD 403. In this study, 10 rats (5 males and 5 females) were exposed to an aerosol atmosphere of the test item at 5.11 mg/L. One day after exposure, all animals exhibited hunched posture and pilo-erection, with occasional instances of sneezing. Noisy respiration was noted in one male. Animals recovered to appear normal from Days 2 to 3 post-exposure, however one male subsequently exhibited noisy respiration from Days 3 to 5 post-exposure and appeared normal from Day 6 post-exposure. All animals exhibited body weight losses or no body weight gain on the first day post-exposure. With the exception of one female from Days 1 to 3 post-exposure and three females from Days 3 to 7 post-exposure which exhibited body weight loss, body weight gains were noted for all animals during the remainder of the recovery period. No macroscopic abnormalities were detected amongst animals at necropsy. The inhalatory LD50 for the substance in male and female rats was determined to be > 5.11 mg/L.